Streetbeat News

Analyst Ratings

VNO

Morgan Stanley analyst Ronald Josey maintains an Underweight rating on Vornado Realty (NYSE:VNO) and lowers the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:53 pm

IOVA

Iovance Biotherapeutics' stock is trading higher after the FDA accepted its Biologics License Application for lifileucel, a TIL therapy for advanced melanoma patients. Analysts from Stifel, Chardan Capital, and HC Wainwright & Co. maintained Buy ratings and raised price targets.

Portfolio Pulse from Adam Eckert

May 30, 2023 | 12:52 pm

STEP

Morgan Stanley analyst Michael Cyprys maintains an Equal-Weight rating on StepStone Group (NASDAQ:STEP) and lowers the price target from $28 to $26.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:52 pm

IFF

SCCO

TROX

Wall Street's most accurate analysts recommend holding three high-yield dividend materials stocks: Southern Copper Corporation (SCCO), Tronox Holdings (TROX), and International Flavors & Fragrances (IFF). These stocks have dividend yields of 5.93%, 4.38%, and 4.14%, respectively.

Portfolio Pulse from Lisa Levin

May 30, 2023 | 12:51 pm

S

Morgan Stanley analyst Hamza Fodderwala maintains an Equal-Weight rating on SentinelOne (NYSE:S) and raises the price target from $16 to $22.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:51 pm

OPI

Morgan Stanley analyst Ronald Kamdem maintains an Underweight rating on Office Props IT (NASDAQ:OPI) and lowers the price target from $11 to $5.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:50 pm

NTR

Morgan Stanley analyst Vincent Sinisi maintains an Equal-Weight rating on Nutrien (NYSE:NTR) and lowers the price target from $80 to $70.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:50 pm

MOS

Morgan Stanley analyst Nigel Dally maintains an Equal-Weight rating on Mosaic (NYSE:MOS) and lowers the price target from $45 to $40.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:49 pm

ICL

Morgan Stanley analyst Nigel Dally maintains an Equal-Weight rating on ICL Group (NYSE:ICL) and lowers the price target from $7.5 to $7.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:48 pm